AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $293 | -99.7% | 14,300 | -16.4% | 0.03% | +400.0% |
Q3 2022 | $85,000 | -53.0% | 17,100 | -34.5% | 0.01% | -33.3% |
Q2 2022 | $181,000 | +42.5% | 26,100 | +91.9% | 0.01% | +80.0% |
Q1 2022 | $127,000 | -77.4% | 13,600 | -64.1% | 0.01% | -66.7% |
Q4 2021 | $561,000 | -39.4% | 37,880 | -13.0% | 0.02% | -50.0% |
Q3 2021 | $926,000 | -39.8% | 43,543 | -5.0% | 0.03% | -37.5% |
Q2 2021 | $1,538,000 | +1485.6% | 45,820 | +163.3% | 0.05% | +1500.0% |
Q4 2020 | $97,000 | +410.5% | 17,400 | -44.1% | 0.00% | +200.0% |
Q3 2020 | $19,000 | -98.5% | 31,100 | -72.3% | 0.00% | -98.5% |
Q2 2020 | $1,246,000 | +20.6% | 112,300 | -46.0% | 0.07% | 0.0% |
Q1 2020 | $1,033,000 | -91.4% | 208,045 | +19.8% | 0.07% | -89.6% |
Q4 2019 | $11,972,000 | +25926.1% | 173,700 | +1226.0% | 0.66% | +16300.0% |
Q3 2019 | $46,000 | – | 13,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |